Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)
Condition: Cataract Interventions: Drug: Clobetasol propionate; Drug: Vehicle Sponsor: Salvat Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2020 Category: Research Source Type: clinical trials